<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Loratadine</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00455</strong>&#160; (APRD00384)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>Loratadine is a derivative of azatadine and a second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (histamine H1 antagonists) it lacks central nervous system depressing effects such as drowsiness. [PubChem]</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00455/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00455/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00455.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00455.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00455.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00455.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00455.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00455">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>Loratadina</td><td>Spanish</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Loratadinum</td><td>Latin</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Salts</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Aerotina</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Alavert</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Biloina</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Civeran</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Claritin</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Fristamin</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Histaloran</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Lomilan</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Loracert</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Loradex</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Loranox</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Lorastine</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Loratadine antihistamine</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Loratyne</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Loritine</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Nularef</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Restamine</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Roletra</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Sensibit</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="mixtures"><thead><tr><th>Brand Name</th><th>Ingredients</th></tr></thead><tbody><tr><td>Chlor-Tripolon ND SRT</td><td>Loratadine + Pseudoephedrine Sulfate</td></tr><tr><td>Clarinase</td><td>Loratadine + Pseudoephedrine Sulfate</td></tr><tr><td>Claritin Allergy + Sinus Extra Strength</td><td>Loratadine + Pseudoephedrine Sulfate</td></tr><tr><td>Claritin-D</td><td>Loratadine + Pseudoephedrine Sulfate</td></tr><tr><td>Liberator</td><td>Loratadine + Pseudoephedrine Sulfate</td></tr></tbody></table></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/anti-allergic-agents">Anti-Allergic Agents</a></li>
<li><a href="/mesh/antipruritics">Antipruritics</a></li>
<li><a href="/mesh/histamine-h1-antagonists-non-sedating">Histamine H1 Antagonists, Non-Sedating</a></li>
<li><a href="/mesh/histamine-antagonists">Histamine Antagonists</a></li></ul></td></tr><tr><th>CAS number</th><td>79794-75-5</td></tr><tr><th>Weight</th><td>Average: 382.883<br>Monoisotopic: 382.144805697</td></tr><tr><th>Chemical Formula</th><td>C<sub>22</sub>H<sub>23</sub>ClN<sub>2</sub>O<sub>2</sub></td></tr><tr><th>InChI Key</th><td>JCCNYMKQOSZNPW-UHFFFAOYSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C22H23ClN2O2/c1-2-27-22(26)25-12-9-15(10-13-25)20-19-8-7-18(23)14-17(19)6-5-16-4-3-11-24-21(16)20/h3-4,7-8,11,14H,2,5-6,9-10,12-13H2,1H3</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">ethyl 4-{13-chloro-4-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-2-ylidene}piperidine-1-carboxylate</div></td></tr><tr><th>SMILES</th><td><div class="wrap">CCOC(=O)N1CCC(CC1)=C1C2=C(CCC3=C1N=CC=C3)C=C(Cl)C=C2</div></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Heterocyclic Compounds</td></tr><tr><th>Class</th><td>Benzocycloheptapyridines</td></tr><tr><th>Subclass</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Direct parent</th><td>Benzocycloheptapyridines</td></tr><tr><th>Alternative parents</th><td>Piperidinecarboxylic Acids; Chlorobenzenes; Pyridines and Derivatives; Aryl Chlorides; Tertiary Amines; Carbamic Acids and Derivatives; Ethers; Polyamines; Organochlorides</td></tr><tr><th>Substituents</th><td>piperidinecarboxylic acid; chlorobenzene; aryl chloride; benzene; pyridine; aryl halide; piperidine; carbamic acid derivative; tertiary amine; polyamine; ether; organochloride; organohalogen; amine; organonitrogen compound</td></tr><tr><th>Classification description</th><td>This compound belongs to the benzocycloheptapyridines. These are aromatic compounds containing a benzene ring and a pyridine ring fused to a seven membered carbocycle.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>A self-medication that is used alone or in combination with pseudoephedrine sulfate for the symptomatic relief of seasonal allergic rhinitis. Also used for the symptomatic relief of pruritus, erythema, and urticaria associated with chronic idiopathic urticaria in patients (not for children under 6 unless directed by a clincian).</td></tr><tr><th>Pharmacodynamics</th><td>Loratadine is a long acting second generation antihistamine that is similar in structure to cyproheptadine and azatadine. The pharmacology of loratadine is similar to other antihistamines, but unlike other H<sub>1</sub>-blockers, loratidine is shown to exhibit competitive, specific, and selective antagonism of H<sub>1</sub> receptors. The exact mechanism of this interaction is unknown, but disposition of the drug suggests that loratadine's prolonged antagonism of histamine may be due to the drug's slow dissociation from the receptor or the formation of the active metabolite, desloratadine. Loratadine does not penetrate the CNS effectively and has a low affinity for CNS H<sub>1</sub>-receptors.</td></tr><tr><th>Mechanism of action</th><td>Loratadine competes with free histamine and exhibits specific, selective peripheral H<sub>1</sub> antagonistic activity. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms (eg. nasal congestion, watery eyes) brought on by histamine. Loratadine has low affinity for cholinergic receptors and does not exhibit any appreciable alpha-adrenergic blocking activity in-vitro. Loratadine also appears to suppress the release of histamine and leukotrienes from animal mast cells, and the release of leukotrienes from human lung fragments, although the clinical importance of this is unknown.</td></tr><tr><th>Absorption</th><td>Rapidly absorbed following oral administration (40% bioavailability)</td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td>97-99%</td></tr><tr><th>Metabolism</th><td class="data-table-container"><p>Hepatic</p><table class="table-standard table-condensed" id="experimental-properties"><thead><tr><th>Substrate</th><th>Enzymes</th><th colspan="2">Product</th></tr></thead><tbody><tr><td>Loratadine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><ul><li><a href="/biodb/bio_entities/BE0002638" target="_blank">Cytochrome P450 3A4</a></li></ul></td><td><a href="/metabolites/DBMET00377">Descarboethoxyloratadine</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/379">Details</a></td></tr></tbody></table></td></tr><tr><th>Route of elimination</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Half life</th><td>8.4 hours</td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td>somnolence, tachycardia, and headache LD<sub>50</sub>=mg/kg (orally in rat)</td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>1.0</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              +
        </td>
        <td>0.9754</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              -
        </td>
        <td>0.5488</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Substrate
        </td>
        <td>0.7337</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Inhibitor
        </td>
        <td>0.9505</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Inhibitor
        </td>
        <td>0.8387</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.5143</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.8197</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Substrate</td>
        <td>0.8918</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Substrate</td>
        <td>0.677</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9045</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Inhibitor</td>
        <td>0.8949</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9231</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Inhibitor</td>
        <td>0.8994</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.831</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>High CYP Inhibitory Promiscuity</td>
        <td>0.9359</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.6884
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.915
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.9963
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          2.8964 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.7531
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Inhibitor 
        </td>
        <td>
            0.8456
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Schering plough healthcare products inc</li>
<li>Taro pharmaceuticals usa inc</li>
<li>Apotex inc richmond hill</li>
<li>L perrigo co</li>
<li>Ranbaxy laboratories ltd</li>
<li>Silarx pharmaceuticals inc</li>
<li>Taro pharmaceutical industries ltd</li>
<li>Teva pharmaceuticals usa inc</li>
<li>Wockhardt eu operations (swiss) ag</li>
<li>Wyeth consumer healthcare</li>
<li>Impax laboratories inc</li>
<li>Watson laboratories inc florida</li>
<li>Apotex inc etobicoke site</li>
<li>Mylan pharmaceuticals inc</li>
<li>Perrigo co</li>
<li>Sandoz inc</li></ul></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://www.amerisourcebergen.com">Amerisource Health Services Corp.</a></li>
<li><a href="http://www.astrazeneca.ca">AstraZeneca Inc.</a></li>
<li><a href="http://www.cardinal.com">Cardinal Health</a></li>
<li><a href="http://www.catalent.com">Catalent Pharma Solutions</a></li>
<li><a href="http://www.chaindrug.com">Chain Drug</a></li>
<li><a href="http://www.stirol.net">Concern Stirol</a></li>
<li><a href="http://www.cvs.com">CVS Pharmacy</a></li>
<li>Direct Dispensing Inc.</li>
<li><a href="http://www.drxdispensing.com">Dispensing Solutions</a></li>
<li><a href="http://www.dhscorp.com">Diversified Healthcare Services Inc.</a></li>
<li><a href="http://hjharkinscompanyinc.com">H.J. Harkins Co. Inc.</a></li>
<li><a href="http://www.majorpharmaceuticals.com">Major Pharmaceuticals</a></li>
<li><a href="http://www.merck.com">Merck &amp; Co.</a></li>
<li>Neuman Distributors Inc.</li>
<li><a href="http://www.novartis.com">Novartis AG</a></li>
<li><a href="http://www.nucarerx.com">Nucare Pharmaceuticals Inc.</a></li>
<li><a href="http://www.patientfirst.com">Patient First Corp.</a></li>
<li><a href="http://www.pdrx.com">PD-Rx Pharmaceuticals Inc.</a></li>
<li><a href="http://www.physicianstotalcare.com">Physicians Total Care Inc.</a></li>
<li><a href="http://www.prepaksys.com">Prepak Systems Inc.</a></li>
<li><a href="http://www.prescript.net">Prescript Pharmaceuticals</a></li>
<li>Professional Co.</li>
<li>S&amp;P Healthcare</li>
<li><a href="http://www.southwoodhealthcare.com">Southwood Pharmaceuticals</a></li>
<li><a href="http://www.walgreens.com">Walgreen Co.</a></li>
<li><a href="http://www.west-ward.com">West-Ward Pharmaceuticals</a></li>
<li><a href="http://www.wockhardtin.com">Wockhardt Ltd.</a></li>
<li><a href="http://www.wyeth.com">Wyeth Pharmaceuticals</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Syrup</td><td>Oral</td><td></td></tr><tr><td>Tablet</td><td>Oral</td><td></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><ul><li><a data-no-turbolink="true" href="/spectra/spectra/c_ms/179">Gas-MS Spectrum</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/nmr_one_d/2015">1H NMR Spectrum</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/nmr_two_d/1950">[1H,13C] 2D NMR Spectrum</a></li></ul></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB01149">Nefazodone</a></td><td>Increased risk of cardiotoxicity</td></tr><tr><td><a href="/drugs/DB00382">Tacrine</a></td><td>The therapeutic effects of the central acetylcholinesterase inhibitor, Tacrine, and/or the anticholinergic, Loratadine, may be reduced due to antagonism. The interaction may be beneficial when the anticholinergic action is a side effect. Monitor for decreased efficacy of both agents.</td></tr><tr><td><a href="/drugs/DB00662">Trimethobenzamide</a></td><td>Trimethobenzamide and Loratadine, two anticholinergics, may cause additive anticholinergic effects and enhance their adverse/toxic effects. Monitor for enhanced anticholinergic effects.</td></tr><tr><td><a href="/drugs/DB00427">Triprolidine</a></td><td>Triprolidine and Loratadine, two anticholinergics, may cause additive anticholinergic effects and enhance their adverse/toxic effects. Additive CNS depressant effects may also occur. Monitor for enhanced anticholinergic and CNS depressant effects.</td></tr><tr><td><a href="/drugs/DB00209">Trospium</a></td><td>Trospium and Loratadine, two anticholinergics, may cause additive anticholinergic effects and enhanced adverse/toxic effects. Monitor for enhanced anticholinergic effects.</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><ul><li>Take on empty stomach: 1 hour before or 2 hours after meals.</li></ul></td></tr></tbody></table>